Boston Scientific to Release Long-Term Clinical Trial Results on Market-Leading TAXUS® Express2™ Coronary Stent System at TCT 2005
(October 10, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company